Nutex Health ROA 2016-2025 | NUTX
Current and historical return on assets (ROA) values for Nutex Health (NUTX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Nutex Health ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $0.07B | $0.76B | 11.95% |
| 2024-12-31 | $0.05B | $0.66B | 11.05% |
| 2024-09-30 | $-0.04B | $0.44B | -9.87% |
| 2024-06-30 | $-0.04B | $0.42B | -8.92% |
| 2024-03-31 | $-0.04B | $0.40B | -9.55% |
| 2023-12-31 | $-0.05B | $0.40B | -10.55% |
| 2023-09-30 | $-0.03B | $0.48B | -6.52% |
| 2023-06-30 | $-0.44B | $0.44B | -100.40% |
| 2023-03-31 | $-0.45B | $0.43B | -83.17% |
| 2022-12-31 | $-0.43B | $0.43B | -93.30% |
| 2022-09-30 | $-0.35B | $0.44B | -79.33% |
| 2022-06-30 | $0.11B | $0.87B | 31.26% |
| 2022-03-31 | $0.16B | $0.08B | 99.06% |
| 2021-12-31 | $0.13B | $0.40B | 84.31% |
| 2021-09-30 | $0.18B | $0.08B | 308.47% |
| 2021-06-30 | $0.13B | $0.08B | 325.00% |
| 2021-03-31 | $0.10B | $0.08B | 457.78% |
| 2020-12-31 | $0.11B | $0.00B | 2120.00% |
| 2020-09-30 | $0.00B | $0.01B | -44.44% |
| 2020-06-30 | $-0.01B | $0.01B | -109.09% |
| 2020-03-31 | $-0.01B | $0.01B | -188.24% |
| 2019-12-31 | $-0.01B | $0.01B | -246.15% |
| 2019-09-30 | $0.00B | $0.00B | -200.00% |
| 2019-06-30 | $0.00B | $0.00B | -171.43% |
| 2019-03-31 | $0.00B | $0.00B | -100.00% |
| 2018-12-31 | $0.00B | $0.00B | -88.89% |
| 2018-09-30 | $-0.01B | $0.00B | -233.33% |
| 2018-06-30 | $0.00B | $0.00B | 0.00% |
| 2018-03-31 | $0.00B | $0.00B | -20.00% |
| 2017-12-31 | $0.00B | $0.00B | 0.00% |
| 2017-09-30 | $0.00B | $0.01B | -80.00% |
| 2017-06-30 | $-0.01B | $0.01B | -450.00% |
| 2017-03-31 | $-0.01B | $0.00B | -2800.00% |
| 2016-12-31 | $-0.01B | $0.00B | -2800.00% |
| 2016-06-30 | $0.00B | $0.00B | 0.00% |
| 2016-03-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.595B | $0.480B |
| Nutex Health Inc. is a physician-led, technology-enabled healthcare services company. The Company's operating divisions include Hospital division and Population Health Management division. Hospital division implements and operates different health care models, including micro hospitals, specialty hospitals and hospital outpatient departments. Population Health Management division owns and operates provider networks such as Independent Physician Associations. Nutex Health Inc., formerly known as Clinigence Holdings Inc., is based in HOUSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $156.252B | 28.69 |
| HCA Healthcare (HCA) | United States | $107.856B | 17.86 |
| CVS Health (CVS) | United States | $98.775B | 11.36 |
| Elevance Health (ELV) | United States | $72.412B | 10.62 |
| Cencora (COR) | United States | $70.172B | 22.64 |
| Natera (NTRA) | United States | $28.194B | 0.00 |
| DiDi Global (DIDIY) | China | $24.803B | 20.27 |
| Labcorp Holdings (LH) | United States | $22.125B | 16.87 |
| Medpace Holdings (MEDP) | United States | $16.622B | 41.26 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.514B | 0.00 |
| Solventum (SOLV) | United States | $13.123B | 12.74 |
| ICON (ICLR) | Ireland | $13.097B | 12.99 |
| Viatris (VTRS) | United States | $12.347B | 4.60 |
| CochLear (CHEOY) | Australia | $11.709B | 0.00 |
| Revvity (RVTY) | United States | $10.513B | 19.36 |
| HealthEquity (HQY) | United States | $8.768B | 35.09 |
| Charles River Laboratories (CRL) | United States | $8.259B | 15.91 |
| Avantor (AVTR) | United States | $7.759B | 11.85 |
| Sonic Healthcare (SKHHY) | Australia | $6.885B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.729B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.771B | 34.41 |
| Bausch + Lomb (BLCO) | Canada | $5.525B | 36.28 |
| Sotera Health (SHC) | United States | $4.443B | 21.42 |
| GeneDx Holdings (WGS) | United States | $3.702B | 65.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.560B | 20.77 |
| Alignment Healthcare (ALHC) | United States | $3.306B | 0.00 |
| Concentras Parent (CON) | United States | $2.489B | 15.54 |
| Premier (PINC) | United States | $2.327B | 22.55 |
| Progyny (PGNY) | United States | $2.117B | 41.61 |
| Pediatrix Medical (MD) | United States | $1.988B | 11.87 |
| Surgery Partners (SGRY) | United States | $1.976B | 25.47 |
| Organon (OGN) | United States | $1.958B | 2.06 |
| Establishment Labs Holdings (ESTA) | $1.859B | 0.00 | |
| PACS (PACS) | United States | $1.612B | 0.00 |
| Ardent Health (ARDT) | United States | $1.289B | 4.21 |
| Teladoc Health (TDOC) | United States | $1.228B | 0.00 |
| Omada Health (OMDA) | $1.161B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.008B | 16.50 |
| Embecta (EMBC) | United States | $0.851B | 4.98 |
| CareDx (CDNA) | United States | $0.820B | 13.39 |
| InnovAge Holding (INNV) | United States | $0.657B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.610B | 8.41 |
| Sonida Senior Living (SNDA) | United States | $0.606B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.500B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.434B | 0.00 |
| Enhabit (EHAB) | United States | $0.409B | 18.39 |
| Strata Critical Medical (SRTA) | United States | $0.391B | 0.00 |
| Pomdoctor - (POM) | China | $0.386B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.383B | 5.76 |
| Oncology Institute (TOI) | United States | $0.371B | 0.00 |
| So-Young (SY) | China | $0.369B | 0.00 |
| SBC Medicals (SBC) | United States | $0.344B | 6.25 |
| Shoulder Innovations (SI) | United States | $0.303B | 0.00 |
| KindlyMD (NAKA) | United States | $0.270B | 0.00 |
| Agilon Health (AGL) | United States | $0.239B | 0.00 |
| LifeMD (LFMD) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.163B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 33.37 |
| Ascend Wellness Holdings (AAWH) | United States | $0.112B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| DocGo (DCGO) | United States | $0.105B | 0.00 |
| Biodesix (BDSX) | United States | $0.064B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.024B | 7.21 |
| Basel Medical Group (BMGL) | Singapore | $0.022B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |